Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN492984 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-WAP Four-Disulfide Core Domain 2 (WFDC2) antibody
- Antibody type
- Polyclonal
- Antigen
- Peptide
- Description
- Affinity chromatography
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Vial size
- 0.1 mg
- Concentration
- 0.68-0.95 mg/mL.
- Storage
- Store (in aliquots) at -20°C.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Comprehensive analysis of HE4 expression in normal and malignant human tissues.
WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung.
A spliced isoform of interleukin 6 mRNA produced by renal cell carcinoma encodes for an interleukin 6 inhibitor.
The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms.
Galgano MT, Hampton GM, Frierson HF Jr
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006 Jun;19(6):847-53
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006 Jun;19(6):847-53
WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung.
Bingle L, Cross SS, High AS, Wallace WA, Rassl D, Yuan G, Hellstrom I, Campos MA, Bingle CD
Respiratory research 2006 Apr 6;7:61
Respiratory research 2006 Apr 6;7:61
A spliced isoform of interleukin 6 mRNA produced by renal cell carcinoma encodes for an interleukin 6 inhibitor.
Alberti L, Bachelot T, Duc A, Biota C, Blay JY
Cancer research 2005 Jan 1;65(1):2-5
Cancer research 2005 Jan 1;65(1):2-5
The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms.
Bingle L, Singleton V, Bingle CD
Oncogene 2002 Apr 18;21(17):2768-73
Oncogene 2002 Apr 18;21(17):2768-73
No comments: Submit comment
No validations: Submit validation data